Artelo Biosciences Inc (ARTL)

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	6.84%2.51	2.69	2.79	3.09	3.15
Research and Development	13.32%0.88	0.77	0.89	1.28	1.87
Interest Income/Expense	94.00%0.01	0.10	0.01	0.11	0.07
Operating Income/Loss	6.84%-2.51	-2.69	-2.79	-3.09	-3.15
Nonoperating Income/Loss	129.00%0.08	-0.27	-1.38	-0.03	-0.07
Income Tax Expense/Benefit	-	-	-	-	-
	17.95%-2.43	-2.96	-4.17	-3.12	-3.22
Attributable To Parent	17.95%-2.43	-2.96	-4.17	-3.12	-3.22
Diluted Average Shares	266.98%2.71	0.74	-	0.79	0.57
Diluted Earnings Per Share	77.75%-0.89	-4.00	-	-3.97	-5.61